PAPER Yamada M, Lamping KG, Duttaroy A, Zhang W, Cui Y, Bymaster FP, McKinzie DL, Felder CC, Deng CX, Faraci FM, Wess J

Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14096-101. PubMed.

PAPER Altmann LJ, Kempler D, Andersen ES

Speech errors in Alzheimer's disease: reevaluating morphosyntactic preservation.

J Speech Lang Hear Res. 2001 Oct;44(5):1069-82. PubMed.

PAPER Zermansky AJ, Bolognani F, Stone D, Cowsill CM, Morrissey G, Castro MG, Löwenstein PR

Towards global and long-term neurological gene therapy: unexpected transgene dependent, high-level, and widespread distribution of HSV-1 thymidine kinase throughout the CNS.

Mol Ther. 2001 Nov;4(5):490-8. PubMed.

PAPER Yu Q, Holloway HW, Flippen-Anderson JL, Hoffman B, Brossi A, Greig NH

Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.

J Med Chem. 2001 Nov 22;44(24):4062-71. PubMed.

PAPER McGeer PL, McGeer EG

Polymorphisms in inflammatory genes and the risk of Alzheimer disease.

Arch Neurol. 2001 Nov;58(11):1790-2. PubMed.

PAPER Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ

Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease.

Arch Neurol. 2001 Nov;58(11):1817-20. PubMed.

PAPER Steinbart EJ, Smith CO, Poorkaj P, Bird TD

Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia.

Arch Neurol. 2001 Nov;58(11):1828-31. PubMed.

PAPER Frisoni GB, Geroldi C

Cerebrovascular disease affects noncognitive symptoms in Alzheimer disease.

Arch Neurol. 2001 Nov;58(11):1939-40. PubMed.

PAPER Thal LJ

Cerebrovascular Disease Affects Noncognitive Symptoms in Alzheimer Disease.

Arch Neurol. 2001 Nov;58(11):1939-1940. PubMed.

PAPER Gunawardena S, Goldstein LS

Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila.

Neuron. 2001 Nov 8;32(3):389-401. PubMed.

PAPER Liu DX, Greene LA

Regulation of neuronal survival and death by E2F-dependent gene repression and derepression.

Neuron. 2001 Nov 8;32(3):425-38. PubMed.

PAPER Croom J, Taylor IL

Neuropeptide Y, peptide YY and aluminum in Alzheimer's disease: is there an etiological relationship?

J Inorg Biochem. 2001 Nov;87(1-2):51-6. PubMed.

PAPER Canales JJ, Corbalán R, Montoliu C, Llansola M, Monfort P, Erceg S, Hernandez-Viadel M, Felipo V

Aluminium impairs the glutamate-nitric oxide-cGMP pathway in cultured neurons and in rat brain in vivo: molecular mechanisms and implications for neuropathology.

J Inorg Biochem. 2001 Nov;87(1-2):63-9. PubMed.

PAPER Niwa K, Porter VA, Kazama K, Cornfield D, Carlson GA, Iadecola C

A beta-peptides enhance vasoconstriction in cerebral circulation.

Am J Physiol Heart Circ Physiol. 2001 Dec;281(6):H2417-24. PubMed.

PAPER Athan ES, Williamson J, Ciappa A, Santana V, Romas SN, Lee JH, Rondon H, Lantigua RA, Medrano M, Torres M, Arawaka S, Rogaeva E, Song YQ, Sato C, Kawarai T, Fafel KC, Boss MA, Seltzer WK, Stern Y, St George-Hyslop P, Tycko B, Mayeux R

A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.

JAMA. 2001 Nov 14;286(18):2257-63. PubMed.